Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ken Herrmann

Showing results (31-40 of 721) with videos related to

Pageof 73
Sort By:
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|January 4, 2022
Advancing Nuclear Medicine in Australia over 3 Decades: A Conversation Between Rodney Hicks, Johannes Czernin, and Ken HerrmannRodney Hicks, Johannes Czernin, Ken Herrmann
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|October 20, 2022
The Future of Targeted α-Therapy Is Bright, but Rigorous Studies Are Necessary to Advance the FieldJonathan Strosberg, Ken Herrmann, Lisa Bodei
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|December 1, 2022
Leading in Urology and Pioneering in Social Media Outreach: A Conversation Among Declan Murphy, Ken Herrmann, and Michael HofmanDeclan Murphy, Ken Herrmann, Michael Hofman
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|October 3, 2025
Resisting RECIST: PSMA PET and Regulatory Change in Prostate CancerOliver Sartor, Louise Emmett, Ken Herrmann
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|October 4, 2016
Evaluation of Prostate Cancer with 11C-Acetate PET/CTClaudio Spick, Ken Herrmann, Johannes Czernin
Cancers|December 10, 2021
In Vivo Targeting of CXCR4-New HorizonsMargret Schottelius, Ken Herrmann, Constantin Lapa
European Journal of Nuclear Medicine and Molecular Imaging|June 27, 2019
EJNMMI supplement: bringing AI and radiomics to nuclear medicinePatrick Veit-Haibach, Irène Buvat, Ken Herrmann
Nuklearmedizin. Nuclear Medicine|April 6, 2021
[Impact of COVID-19 on Nuclear Medicine Procedures in Germany 2020 - Results of a National Survey]Lutz S Freudenberg, Markus Essler, Ken Herrmann
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|April 24, 2021
Nuclear Medicine Beyond VISIONWolfgang P Fendler, Ken Herrmann, Matthias Eiber
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|January 17, 2025
From Scientist to Analyst to Strategist: Aharon (Ronny) Gal Talks with Ken Herrmann and Johannes Czernin About Leadership in Multinational PharmaAharon Ronny Gal, Ken Herrmann, Johannes Czernin
Pageof 73

Showing results (31-40 of 721) with videos related to

Sort By:
Pageof 73
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|January 4, 2022
Advancing Nuclear Medicine in Australia over 3 Decades: A Conversation Between Rodney Hicks, Johannes Czernin, and Ken HerrmannRodney Hicks, Johannes Czernin, Ken Herrmann
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|October 20, 2022
The Future of Targeted α-Therapy Is Bright, but Rigorous Studies Are Necessary to Advance the FieldJonathan Strosberg, Ken Herrmann, Lisa Bodei
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|December 1, 2022
Leading in Urology and Pioneering in Social Media Outreach: A Conversation Among Declan Murphy, Ken Herrmann, and Michael HofmanDeclan Murphy, Ken Herrmann, Michael Hofman
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|October 3, 2025
Resisting RECIST: PSMA PET and Regulatory Change in Prostate CancerOliver Sartor, Louise Emmett, Ken Herrmann
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|October 4, 2016
Evaluation of Prostate Cancer with 11C-Acetate PET/CTClaudio Spick, Ken Herrmann, Johannes Czernin
Cancers|December 10, 2021
In Vivo Targeting of CXCR4-New HorizonsMargret Schottelius, Ken Herrmann, Constantin Lapa
European Journal of Nuclear Medicine and Molecular Imaging|June 27, 2019
EJNMMI supplement: bringing AI and radiomics to nuclear medicinePatrick Veit-Haibach, Irène Buvat, Ken Herrmann
Nuklearmedizin. Nuclear Medicine|April 6, 2021
[Impact of COVID-19 on Nuclear Medicine Procedures in Germany 2020 - Results of a National Survey]Lutz S Freudenberg, Markus Essler, Ken Herrmann
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|April 24, 2021
Nuclear Medicine Beyond VISIONWolfgang P Fendler, Ken Herrmann, Matthias Eiber
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|January 17, 2025
From Scientist to Analyst to Strategist: Aharon (Ronny) Gal Talks with Ken Herrmann and Johannes Czernin About Leadership in Multinational PharmaAharon Ronny Gal, Ken Herrmann, Johannes Czernin
Pageof 73